SEC Form 4 · accession 0001209191-15-068192
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane Wasman
Officer — President, Intl and GC
Period of report
Aug 25, 2015
Accepted (ET)
Aug 27, 2015 · 3:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 101,847 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $31.37 | Aug 25, 2015 | A | 10,000 | A | — | Aug 25, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The shares subject to this option were fully vested upon grant.